Medical/Pharmaceuticals
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
TAINAN, April 9, 2026 /PRNewswire/ -- Towards Buddha Co., Ltd., a Taiwan-based manufacturer of medical-grade plastic components, will exhibit at Medtec Japan 2026 this April, presenting its integrated TPU tubing injection manufacturing solutions in collaboration with ICP DAS BMP, a supplier of h...
World's First CAR-T Therapy for Solid Tumors Available in China Soon
A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer tr...
World's First CAR-T Therapy for Solid Tumors Available in China Soon
A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer tr...
Manulife Partners with Mind HK to Establish New Wellbeing Consultation Hub in Mong Kok
Free one-on-one, in-person mental health consultations to enhance community access to timely psychological support HONG KONG, April 9, 2026 /PRNewswire/ -- Manulife Hong Kong ("Manulife") today announced an expansion of its long‑standing partnership with its strategic charity partner Mind HK, wi...
Shaklee Announces Appointment of New General Manager for Australia and New Zealand
MIAMI, April 9, 2026 /PRNewswire/ -- Shaklee, a global leader in health and
wellness, announced the appointment of Bianca Cosentino as General Manager of
Shaklee Australia and New Zealand, effective March 26th, 2026.
Telix Strengthens Board with Additional Director Appointments
MELBOURNE, Australia and INDIANAPOLIS, April 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces two additional Non-Executive Director (NED) appointments, effective May 11, 2026[1] , as part of Board expansion and succession planning: ...
First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
SHANGHAI, April 8, 2026 /PRNewswire/ -- On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by Kingstron...
MALAYSIA HEALTHCARE WEEK KICKS OFF IN DHAKA AS BANGLADESH'S PATIENT MARKET SHIFTS
DHAKA, Bangladesh, April 8, 2026 /PRNewswire/ -- Malaysia Healthcare Week in Dhaka 2026 has officially commenced, bringing Malaysia's healthcare expertise directly to Bangladeshi patients, partners and industry stakeholders as demand for overseas medical treatment continues to rise across the cou...
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Milestones underscore clinical progress and strengthen commercial foundation
LOS GATOS, Calif., April 8, 2026 /PRNewswire/ -- Supira Medical, Inc.
Portrai to Present 11 Posters on AI-Driven Spatial Transcriptomics at AACR 2026
The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial t...
"Lactobacillus Rhamnosus L34": A Native Probiotic That Reduces Inflammation in Patients with Chronic Kidney Disease
BANGKOK, April 8, 2026 /PRNewswire/ -- Researchers from the Faculty of Medicine
at Chulalongkorn University
ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation
SHANGHAI, April 7, 2026 /PRNewswire/ -- ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreement with Daiichi Sankyo to leverage ATLATL's multi-regional innovative R&D network and expertise in the...
Lumonus launches strategic collaboration with leading global cancer center to advance radiation therapy treatment planning
SYDNEY and NEW YORK, April 8, 2026 /PRNewswire/ -- Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), one of the world's premier cancer cen...
Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited
* Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products * Aggregate consideration of USD250,000,000 (approximately RMB1,721,650,000), payable in three installments * Delivers near-term revenue and profitability wi...
LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market
NORWALK, Conn., April 8, 2026 /PRNewswire/ -- LBB Specialties (LBBS), a North
American distributor ofspecialty chemicals and ingredients
Live Cell Observation System Selected for NASA-Supported Project Heading to the International Space Station
Nikon Contributes to Research on the Effects of Microgravity in Drug Discovery TOKYO, April 7, 2026 /PRNewswire/ -- Nikon Corporation (Nikon) is pleased to announce that the live cell observation system developed by Nikon and its U.S.-based subsidiary Nikon Instruments Inc. (NII) has been selecte...
Singlomics Announces First Patient Dosed in Phase I Clinical Trial of DXP-106 (IL-1RAP mAb) in China
BEIJING, April 7, 2026 /PRNewswire/ -- Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for oncology, inflammation, and autoimmune diseases, today announced that the first patient has been dosed...
TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom, April 7, 2026 /PRNewswire/ -- TriNetX, the world's leading federated health data netwo...
Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has receive...
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study. The fixed dose combination had excellent oral bioavailability, drug exposure and a half-lif...
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 327 media titles]
2026-08-05 11:34MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 313 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 299 media titles]
2026-08-06 15:10Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 298 media titles]
2026-08-04 07:00Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 294 media titles]
2026-08-04 14:30